Skip to content

VARIABLE-PSV Study

Evaluation a New Ventilatory Modes: VARIABLE-PSV: a Randomized Controlled Cross-over Study: the VARIABLE-PSV Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01580956
Enrollment
20
Registered
2012-04-19
Start date
2012-04-30
Completion date
2012-08-31
Last updated
2013-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure, Critical Illness, Ventilation Weaning

Keywords

Acute respiratory failure, Critical illness, Mechanical ventilation, Ventilation weaning, Intensive Care Unit, Variable (NOISY) PSV, PSV

Brief summary

Variable PSV is a new ventilatory mode which delivered a pressure support variable from 0 to 100% variation of the set PSV level.This study aimed to compare the ventilatory behavior, sleep quality and gas exchange between VARIABLE (or Noisy)-PSV and standard (or fixed)-PSV during the weaning phase of critically ill patients who required mechanical ventilation.

Detailed description

Twenty patients will be enrolled. They will be ventilated withVARIABLE-PSV and STANDARD-PSV: for 24 h each in a randomized crossover order. The ventilatory parameters, ventilator/patient asynchrony, gas exchange effects, sleep quality and ventilatory comfort produced by the two ventilation modes will be compared. Before randomisation, a sequence of VARIABLE-PSV will be performed with different level of variation setting to better define the future behavior of the patient under this mode during the 24 h of Variable-PSV.

Interventions

OTHERVARIABLE-PSV ventilatory mode

The two ventilatory modes will be studied during 24h in intubated patients in random order.

OTHERSTANDARD-PSV ventilatory mode

The two ventilatory modes will be studied during 24h in intubated patients in random order.

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ventilation planned for more than 48 h * patient alert and calm corresponding to a Richmond Agitation-Sedation Scale (RASS) between -2 and 0 * Age \> or equal 18 * Surrogate decision maker's consent

Exclusion criteria

* Clinical instability for any reason. * Life support withdrawal code * Patient under tutelage * Pregnancy * No French health insurance

Design outcomes

Primary

MeasureTime frameDescription
Oxygenation in each ventilatory modeafter 24h of mechanical ventilation in each modeWe will performed arterial blood gases and oxygenation wil be evaluated by the PaO2/FiO2 ration.

Secondary

MeasureTime frameDescription
Ventilatory comfortduring 24h in each modeComfort zone is defined as previously reported in some papers as considered adequate ventilation : 6 \< tidal volume \< 10 ml/kg, ETCO2 \< 55 mmHg and \< 65 mmHg for COPD patients and 12 \< Respiratory rate \< 35 cycles/min.
Feasibilityduring the 24 hoursEvaluation of time spent in each mode during the 24 hours of ventilation without any side effects and switch for another ventilatory mode.
Patient/ventilator asynchronismduring the 24 hoursEvaluation of number of asynchrony evaluated by an Asynchrony Index (AI) in each mode during the 24 hours of mechanical ventilation
Ventilatory effectsduring the 24 hoursEvaluation of machine ventilatory behaviors in each mode during the 24 hours of mechanical ventilation.
Sleep qualityafter the 24 hoursEvaluation of quality of sleep in each mode after the 24h of mechanical ventilation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026